"Molybdenum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.95. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase.
| Descriptor ID |
D008982
|
| MeSH Number(s) |
D01.268.556.555 D01.268.956.500 D01.552.544.555
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Molybdenum".
Below are MeSH descriptors whose meaning is more specific than "Molybdenum".
This graph shows the total number of publications written about "Molybdenum" by people in this website by year, and whether "Molybdenum" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Molybdenum" by people in Profiles.
-
Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002 Sep 1; 62(17):4854-9.
-
van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, Merajver SD. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia. 2002 Sep-Oct; 4(5):373-9.
-
Khan MK, Miller MW, Taylor J, Gill NK, Dick RD, Van Golen K, Brewer GJ, Merajver SD. Radiotherapy and antiangiogenic TM in lung cancer. Neoplasia. 2002 Mar-Apr; 4(2):164-70.